{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T23:00:34Z","timestamp":1771455634018,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.bbi.2007.06.009","type":"journal-article","created":{"date-parts":[[2007,8,4]],"date-time":"2007-08-04T07:11:35Z","timestamp":1186211495000},"page":"89-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation"],"prefix":"10.1016","volume":"22","author":[{"given":"Timothy B.","family":"Saurer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie G.","family":"Ijames","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly A.","family":"Carrigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald T.","family":"Lysle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2007.06.009_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00006842-197507000-00007","article-title":"Behaviorally conditioned immunosuppression","volume":"37","author":"Ader","year":"1975","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.bbi.2007.06.009_bib2","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.7063864","article-title":"Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus","volume":"215","author":"Ader","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.bbi.2007.06.009_bib3","series-title":"Psychoneuroimmunology","first-page":"3","article-title":"Conditioning and immunity","author":"Ader","year":"2001"},{"key":"10.1016\/j.bbi.2007.06.009_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0192-0561(79)90017-1","article-title":"Adrenal involvement in conditioned immunosuppression","volume":"1","author":"Ader","year":"1979","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.bbi.2007.06.009_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0165-5728(02)00278-3","article-title":"NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo: sympathetic co-transmission during leukocyte mobilization","volume":"132","author":"Bedoui","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.06.009_bib6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0022-3565(25)10129-8","article-title":"\u03b1-Adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity","volume":"264","author":"Carr","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2007.06.009_bib7","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1046\/j.1460-9568.2003.02849.x","article-title":"Dopamine efflux in nucleus accumbens shell and core in response to appetitive classical conditioning","volume":"18","author":"Cheng","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbi.2007.06.009_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0165-5728(92)90256-K","article-title":"Pavlovian conditioning of morphine-induced alterations of immune status","volume":"39","author":"Coussons","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.06.009_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-5728(94)90003-5","article-title":"Pavlovian conditioning of morphine-induced alterations of immune status: evidence for opioid receptor involvement","volume":"55","author":"Coussons-Read","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.06.009_bib10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/brbi.1994.1019","article-title":"Pavlovian conditioning of morphine-induced alterations of immune status: evidence for peripheral \u03b2-adrenergic receptor involvement","volume":"8","author":"Coussons-Read","year":"1994","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2007.06.009_bib11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0889-1591(88)90011-6","article-title":"Shock-induced modulation of lymphocyte responsiveness and natural killer activity: differential mechanisms of induction","volume":"2","author":"Cunnick","year":"1988","journal-title":"Brain Behav. Immun."},{"issue":"Suppl 1","key":"10.1016\/j.bbi.2007.06.009_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuropharm.2004.06.032","article-title":"Dopamine and drug addiction: the nucleus accumbens shell connection","volume":"47","author":"Di Chiara","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbi.2007.06.009_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0167-0115(96)00074-2","article-title":"BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties","volume":"65","author":"Doods","year":"1996","journal-title":"Regul. Pept."},{"key":"10.1016\/j.bbi.2007.06.009_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0165-5728(98)00122-2","article-title":"Behaviorally conditioned immunosuppression using cyclosporine A: central nervous system reduces IL-2 production via splenic innervation","volume":"88","author":"Exton","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.06.009_bib15","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0022-3565(25)38238-8","article-title":"Evidence for \u03b2-adrenergic-receptor involvement in the immunomodulatory effects of morphine","volume":"265","author":"Fecho","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2007.06.009_bib16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0022-3565(25)12317-3","article-title":"Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats","volume":"276","author":"Fecho","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2007.06.009_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-3565(25)12916-9","article-title":"Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats","volume":"277","author":"Fecho","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2007.06.009_bib18","doi-asserted-by":"crossref","first-page":"755s","DOI":"10.4049\/jimmunol.135.2.755","article-title":"Noradrenergic and peptidergic innervation of lymphoid tissue","volume":"135","author":"Felten","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2007.06.009_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/jnr.490180108","article-title":"Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synapticlike contacts on lymphocytes in the splenic white pulp","volume":"18","author":"Felten","year":"1987","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbi.2007.06.009_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0306-4522(91)90202-Y","article-title":"Specificity in the projection patterns of accumbal core and shell in the rat","volume":"41","author":"Heimer","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2007.06.009_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-3565(25)12679-7","article-title":"Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cytotoxicity","volume":"255","author":"Irwin","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2007.06.009_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1113\/jphysiol.1993.sp019898","article-title":"Hypothalamic modulation of splenic natural killer cell activity in rats","volume":"471","author":"Katafuchi","year":"1993","journal-title":"J. Physiol"},{"key":"10.1016\/j.bbi.2007.06.009_bib23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1037\/0735-7044.97.4.663","article-title":"Pavlovian conditioning of immunosuppression modifies adjuvant arthritis in rats","volume":"97","author":"Klosterhalfen","year":"1983","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.bbi.2007.06.009_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0301-0511(89)90109-9","article-title":"Immunomodulation by behavioural conditioning","volume":"28","author":"Kusnecov","year":"1989","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.bbi.2007.06.009_bib25","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0024-3205(76)90417-3","article-title":"Naloxone antagonism of conditioned hyperthermia: an evidence for release of endogenous opioid","volume":"18","author":"Lal","year":"1976","journal-title":"Life Sci."},{"key":"10.1016\/j.bbi.2007.06.009_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0091-3057(75)90146-X","article-title":"Antagonism of morphine-induced aversive conditioning by naloxone","volume":"3","author":"Leblanc","year":"1975","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbi.2007.06.009_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0165-5728(92)90014-C","article-title":"Evidence for the involvement of \u03b2-adrenergic receptors in conditioned immunomodulation","volume":"38","author":"Luecken","year":"1992","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.06.009_bib28","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-3565(25)38224-8","article-title":"Morphine-Induced Alterations of Immune Status - Dose Dependency, Compartment Specificity and Antagonism by Naltrexone","volume":"265","author":"Lysle","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2007.06.009_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0889-1591(92)90017-I","article-title":"Modulation of immune status by a conditioned aversive stimulus: evidence for the involvement of endogenous opioids","volume":"6","author":"Lysle","year":"1992","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2007.06.009_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0889-1591(92)90060-2","article-title":"Suppression of the development of adjuvant arthritis by a conditioned aversive stimulus","volume":"6","author":"Lysle","year":"1992","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2007.06.009_bib31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/BF02244224","article-title":"Conditioning of morphine-induced taste aversion and analgesia","volume":"101","author":"Miller","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbi.2007.06.009_bib32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/brbi.1993.1007","article-title":"Effect of neuropeptide Y on natural killer activity of normal human lymphocytes","volume":"7","author":"Nair","year":"1993","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2007.06.009_bib33","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.bbi.2007.06.009_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0165-5728(97)00106-9","article-title":"Conditioned immunomodulation: investigations of the role of endogenous activity at mu, kappa, and delta opioid receptor subtypes","volume":"79","author":"Perez","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.06.009_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0165-5728(94)90234-8","article-title":"Molecular cloning of NPY-Y1 receptor cDNA from rat splenic lymphocytes: evidence of low levels of mRNA expression and [125I]NPY binding sites.","volume":"54","author":"Petitto","year":"1994","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.06.009_bib36","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.pneurobio.2004.09.004","article-title":"Mesolimbic dopaminergic pathways in fear conditioning","volume":"74","author":"Pezze","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbi.2007.06.009_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0306-4522(01)00403-1","article-title":"Selective responding of nucleus accumbens core and shell dopamine to aversively conditioned contextual and discrete stimuli","volume":"108","author":"Pezze","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2007.06.009_bib38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0091-3057(96)00567-9","article-title":"Involvement of opioid mu 1 receptors in morphine-induced conditioned place preference in rats","volume":"58","author":"Piepponen","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbi.2007.06.009_bib39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0022-1759(84)90154-6","article-title":"The standardization of Nk cell assays for use in studies of biological response modifiers","volume":"68","author":"Pross","year":"1984","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbi.2007.06.009_bib40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0889-1591(91)90025-6","article-title":"Conditioned immunosuppression of a murine delayed type hypersensitivity response: dissociation from corticosterone elevation","volume":"5","author":"Roudebush","year":"1991","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2007.06.009_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2005.11.009","article-title":"Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell","volume":"173","author":"Saurer","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.06.009_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jneuroim.2006.05.002","article-title":"Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity","volume":"177","author":"Saurer","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.06.009_bib43","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1073\/pnas.83.18.7114","article-title":"Involvement of brain opiate receptors in the immune-suppressive effect of morphine","volume":"83","author":"Shavit","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbi.2007.06.009_bib44","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.6691146","article-title":"Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity","volume":"223","author":"Shavit","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.bbi.2007.06.009_bib45","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-006-0673-z","article-title":"Conditioned effects of heroin on the expression of inducible nitric oxide synthase in the rat are susceptible to extinction and latent inhibition","author":"Szczytkowski","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbi.2007.06.009_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0006-8993(98)00359-X","article-title":"Efferent projections of the nucleus accumbens in the rat with special reference to subdivision of the nucleus: biotinylated dextran amine study","volume":"797","author":"Usuda","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2007.06.009_bib47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0165-5728(96)00040-9","article-title":"Acute electrical stimulation of lateral hypothalamus increases natural killer cell activity in rats","volume":"67","author":"Wenner","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.06.009_bib48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0165-5728(03)00214-5","article-title":"Chronic electrical stimulation of the lateral hypothalamus increases natural killer cell cytotoxicity in rats","volume":"141","author":"Wrona","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2007.06.009_bib49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jneuroim.2005.02.017","article-title":"Suppression of natural killer cell cytotoxicity following chronic electrical stimulation of the ventromedial hypothalamic nucleus in rats","volume":"163","author":"Wrona","year":"2005","journal-title":"J. Neuroimmunol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915910700150X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915910700150X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:17:56Z","timestamp":1760167076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088915910700150X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S088915910700150X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2007.06.009","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2007.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}